Annual Shareholders Equity
$1.02 B
+$678.43 M+197.02%
December 1, 2024
Summary
- As of March 10, 2025, JANX annual stockholders equity is $1.02 billion, with the most recent change of +$678.43 million (+197.02%) on December 1, 2024.
- During the last 3 years, JANX annual shareholders equity has risen by +$656.45 million (+179.20%).
- JANX annual shareholders equity is now at all-time high.
Performance
JANX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.02 B
+$366.68 M+55.89%
December 1, 2024
Summary
- As of March 10, 2025, JANX quarterly stockholders equity is $1.02 billion, with the most recent change of +$366.68 million (+55.89%) on December 1, 2024.
- Over the past year, JANX quarterly shareholders equity has stayed the same.
- JANX quarterly shareholders equity is now at all-time high.
Performance
JANX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
JANX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +197.0% | 0.0% |
| 3 y3 years | +179.2% | 0.0% |
| 5 y5 years | +10000.0% | 0.0% |
JANX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +218.9% | at high | +241.5% |
| 5 y | 5-year | at high | +7087.2% | at high | +6198.5% |
| alltime | all time | at high | +7087.2% | at high | +6198.5% |
Janux Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.02 B(+197.0%) | $1.02 B(+55.9%) |
| Sep 2024 | - | $656.10 M(-0.2%) |
| Jun 2024 | - | $657.68 M(+0.3%) |
| Mar 2024 | - | $655.76 M(+90.4%) |
| Dec 2023 | $344.35 M(+7.4%) | $344.35 M(-1.3%) |
| Sep 2023 | - | $348.95 M(+16.5%) |
| Jun 2023 | - | $299.47 M(-3.8%) |
| Mar 2023 | - | $311.26 M(-3.0%) |
| Dec 2022 | $320.74 M | $320.74 M(-3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $331.51 M(-3.6%) |
| Jun 2022 | - | $343.81 M(-3.4%) |
| Mar 2022 | - | $356.08 M(-2.8%) |
| Dec 2021 | $366.33 M(-2602.6%) | $366.33 M(-2.8%) |
| Sep 2021 | - | $376.75 M(-2.1%) |
| Jun 2021 | - | $384.80 M(-2394.4%) |
| Mar 2021 | - | -$16.77 M(+14.6%) |
| Dec 2020 | -$14.64 M(+84.3%) | -$14.64 M |
| Dec 2019 | -$7.94 M | - |
FAQ
- What is Janux Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Janux Therapeutics?
- What is Janux Therapeutics annual shareholders equity year-on-year change?
- What is Janux Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Janux Therapeutics?
- What is Janux Therapeutics quarterly shareholders equity year-on-year change?
What is Janux Therapeutics annual stockholders equity?
The current annual shareholders equity of JANX is $1.02 B
What is the all time high annual shareholders equity for Janux Therapeutics?
Janux Therapeutics all-time high annual stockholders equity is $1.02 B
What is Janux Therapeutics annual shareholders equity year-on-year change?
Over the past year, JANX annual stockholders equity has changed by +$678.43 M (+197.02%)
What is Janux Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of JANX is $1.02 B
What is the all time high quarterly shareholders equity for Janux Therapeutics?
Janux Therapeutics all-time high quarterly stockholders equity is $1.02 B
What is Janux Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, JANX quarterly stockholders equity has changed by $0.00 (0.00%)